[Apoptosis and chemotherapy].
Bettaieb
A
A
CJF Inserm U. 517, Groupe biologie et thérapie des cancers (JE515), Facultés de médecine et de pharmacie, 7, boulevard Jeanne-d'Arc, 21033 Dijon Cedex.
Sordet
O
O
Belon
J P
JP
Solary
E
E
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000502:physiology*; D020169:Caspases / Q000187:drug effects / Q000502:physiology*; D004260:DNA Repair; D004273:DNA, Neoplasm / Q000187:drug effects; D019008:Drug Resistance, Neoplasm; D009363:Neoplasm Proteins / Q000502:physiology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000502:physiology; D013997:Time Factors
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D020169:Caspases